Duke Rohlen is the founder of Cortex. Cortex has raised $90M in total funding. Latest round: Series A. Backed by KKR, Hellman & Friedman, AI Life Sciences.
Duke Rohlen is a serial medtech entrepreneur and the Founder, CEO, and Chairman of Cortex, an Ajax Health company developing atrial fibrillation ablation technology. He has founded five companies with over $1.7 billion in total exits, including FoxHollow Technologies and CV Ingenuity which were sold for a combined $1 billion. Rohlen has over two decades of experience in medical devices.
Full founder directory · Investor directory · Company funding database · Fundraising library